Medipharm Labs Corp T.LABS

F.Y.I.

[subaru1]

1. MediPharm Labs Corporation (TSX: LABS) (OTC: MEDIF) was downgraded and received a price target cut from Canaccord Genuity. The broker-dealer changed the rating to Hold from Speculative Buy and lowered the price target to C$0.25 from C$0.70

[mdjbrown]

How many times do you see good ole Canaccord lower price objectives to buy a boatload for the upcoming run up. MediPharm Labs (TSE:LABS) was downgraded by equities researchers at Canaccord Genuity to a “hold” rating in a research report issued to clients and investors on Tuesday, TipRanks reports. They currently have a C$0.35 price objective on the stock. Canaccord Genuity’s

[Starkicker]

Upcoming run up based on what? There are absolutely no indicators suggesting anything other than a slide into oblivion.

[mdjbrown]

Watch and learn grasshopper  lol The expanding International foundation is being built by the day and Medipharm is already touted as a North American leader in its infant field. Once medicinal CBD becomes mainstream globally, Labs will be set up in a really good spot to flourish. If its instant gratification you seek, it wont be here, but the snowball is starting to roll Just like EV',

[Starkicker]

I hope you're right, but I just don't see any miracles happening anytime soon. As for instant gratification, I bought in at the IPO and shed some shares at $7 but still hold a few so I'm good.

[mdjbrown]

As with any new sector it takes time to prove, and there are certainly enough non believers out there Sk. It is unlikely the new CEO signed on to keep an empty seat of a sinking ship warm until it sinks to the bottom, so we will see I did expect at least one positive announcement this week to get things moving though